From Ground Zero to Oncology Care: A Daiichi Sankyo Leader's Journey
核心洞察
John Ruggiero, Executive Director of U.S. Medical Affairs, HEOR at Daiichi Sankyo, reflects on his path from serving at Ground Zero after 9/11 to the pharmaceutical industry.
His story is featured in Daiichi Sankyo's "Where Craft Meets" series, which highlights the people behind the company's medicines and their collective mission to help patients.
Ruggiero discusses how his unique experiences and craft shape his work in oncology care and health economics and outcomes research.
Behind every medicine lies a human story, and for John Ruggiero, Executive Director of U.S. Medical Affairs, Health Economics and Outcomes Research (HEOR) at Daiichi Sankyo, that story began at Ground Zero in New York City. In the aftermath of the September 11th attacks, Ruggiero served on the frontlines — an experience that would ultimately shape his path into the pharmaceutical industry and his commitment to patient care.
Ruggiero's journey is the focus of the latest installment in Daiichi Sankyo's "Where Craft Meets" series, which explores and celebrates the people behind the company's medicines and shares how their unique crafts contribute to the collective mission of helping patients.
Reflecting on the experiences that led him to the pharmaceutical industry, Ruggiero discusses how his craft shapes his work today and the organizational culture that continues to inspire him at Daiichi Sankyo. His transition from emergency response to oncology care represents a through-line of service — from addressing immediate, acute needs at one of the nation's most devastating moments to contributing to long-term therapeutic solutions for patients facing cancer.
The profile highlights the intersection of personal experience and professional purpose, illustrating how individual journeys inform the broader mission of pharmaceutical research and development. As Executive Director of U.S. Medical Affairs, HEOR, Ruggiero plays a role in evaluating the real-world value and outcomes of therapies, bridging clinical data with patient impact.
Daiichi Sankyo's "Where Craft Meets" series underscores the company's recognition that scientific innovation is driven by people — their backgrounds, their dedication, and the distinct skills they bring to the mission of advancing patient care.